Private label minoxidil 5%
This article was originally published in The Rose Sheet
Executive Summary
Alpharma abbreviated new drug application (75-518) for private label version of Pharmacia & Upjohn's Rogaine Extra Strength for Men tentatively approved July 22. Three-year marketing exclusivity for P&U's 5% minoxidil topical solution expires Nov. 14, 2000
You may also be interested in...
Perrigo
Private label manufacturer expects FDA tentative approval of its abbreviated new drug application for 5% minoxidil topical solution "well before" the three-year marketing exclusivity for Pharmacia & Upjohn expires Nov. 14, 2000. Alpharma's ANDA for private label version of P&U's Rogaine Extra Strength for Men was tentatively approved July 22 (1"The Rose Sheet" Aug. 2, In Brief)
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program